Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 37 | 34 | 38 | 61 |
| Receivables | 93 | 52 | 43 | 21 | 87 |
| TOTAL | $95 | $89 | $77 | $59 | $148 |
| Non-Current Assets | |||||
| PPE Net | 624 | 664 | 704 | 743 | 783 |
| Other Non-Current Assets | 86 | 72 | 60 | 73 | 121 |
| TOTAL | $710 | $736 | $764 | $816 | $904 |
| Total Assets | $805 | $825 | $841 | $875 | $1,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 264 | 206 | 412 | 443 | 461 |
| Accounts payable and accrued liabilities | 3,008 | 2,818 | 2,629 | 2,416 | 2,242 |
| TOTAL | $3,272 | $3,024 | $3,041 | $2,859 | $2,703 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 101 | 93 | 81 | 92 | 136 |
| TOTAL | $101 | $93 | $81 | $92 | $136 |
| Total Liabilities | $3,373 | $3,117 | $3,122 | $2,951 | $2,839 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 320 | 266 | 246 | 246 | 246 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -37,638 | -37,017 | -36,474 | -35,960 | -35,334 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 133 |
| TOTAL | $-2,568 | $-2,292 | $-2,281 | $-2,076 | $-1,787 |
| Total Liabilities And Equity | $805 | $825 | $841 | $875 | $1,052 |